CCL2 has been previously reported as expressed in human bone marrow endothelial cells; the CCL2 stimulation promotes prostate cancer cell migration and proliferation [57], [59] and it has been proposed as a paracrine and autocrine factor for invasion and growth of prostate cancer [60]. The gene discussed is CCL2; the disease is prostate carcinoma.